Eric Rondeau
Overview
Explore the profile of Eric Rondeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
3653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cremoni M, Teisseyre M, Thaunat O, Fernandez C, Payre C, Moutou A, et al.
Kidney Int Rep
. 2024 Dec;
9(12):3427-3438.
PMID: 39698349
Introduction: Membranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival. Methods: We conducted...
2.
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum
Kavanagh D, Ardissino G, Brocklebank V, Bouwmeester R, Bagga A, Ter Heine R, et al.
Kidney Int
. 2024 Oct;
106(6):1038-1050.
PMID: 39395628
Hemolytic uremic syndromes (HUSs) are a heterogeneous group of conditions, only some of which are mediated by complement (complement-mediated HUS). We report the outcome of the 2023 International Society of...
3.
Irish G, Fadhil R, Rondeau E, Nagral S, Ahmadipour M, Coates P, et al.
Transplant Direct
. 2024 Jun;
10(7):e1655.
PMID: 38881742
Background: Lack of data regarding international travel for organ transplantation (ITOT) hampers efforts to evaluate, understand, and respond to trends in ITOT activities, such as those suggestive of organ trafficking...
4.
Niasse A, Louis K, Lenoir O, Schwarz C, Xu X, Couturier A, et al.
Kidney Int Rep
. 2024 May;
9(4):1093-1106.
PMID: 38765560
Introduction: During glomerular diseases, podocyte-specific pathways can modulate the intensity of histological disease and prognosis. The therapeutic targeting of these pathways could thus improve the management and prognosis of kidney...
5.
Licht C, Al-Dakkak I, Anokhina K, Isbel N, Fremeaux-Bacchi V, Gilbert R, et al.
Nephrology (Carlton)
. 2024 Apr;
29(8):519-527.
PMID: 38604995
Introduction: Atypical haemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) associated with complement dysregulation; aHUS may be associated with other 'triggers' or 'clinical conditions'. This study...
6.
Stock P, Nagral S, Rondeau E, Gawronska S, Groverman J, Barbari A, et al.
Transplantation
. 2024 Feb;
108(7):1476-1487.
PMID: 38383953
Global conflicts and humanitarian crises have resulted in an unprecedented number of refugees and migrants. This challenges the limited resources of health care systems and jeopardizes the availability of transplant...
7.
Dubourg Q, Savoye E, Drouin S, Legeai C, Barrou B, Rondeau E, et al.
Transplantation
. 2023 Oct;
108(3):768-776.
PMID: 37819189
Background: Cardiac arrest (CA) causes renal ischemia in one-third of brain-dead kidney donors before procurement. We hypothesized that the graft function depends on the time interval between CA and organ...
8.
Schwarz C, Georgin-Lavialle S, Lombardi Y, Marion O, Jambon F, Legendre C, et al.
Am J Kidney Dis
. 2023 Sep;
83(3):329-339.
PMID: 37741608
Rationale & Objective: Outcomes of kidney transplantation for patients with renal AA amyloidosis are uncertain, with reports of poor survival and high rates of disease recurrence. However, the data are...
9.
Bureau C, Rafat C, Taupin J, Malard S, Mesnard L, Francois H, et al.
Transpl Int
. 2023 Sep;
36:11212.
PMID: 37680645
Whether immunoadsorption (IADS) as part of desensitization protocols could facilitate deceased donor kidney transplantation (KT) in highly sensitized (HS) patients remains to be proven. We retrospectively analyzed our IADS based...
10.
Schwarz C, Morel A, Matignon M, Grimbert P, Rondeau E, Ouali N, et al.
Kidney Int Rep
. 2023 Aug;
8(8):1531-1541.
PMID: 37547512
Introduction: Hepatitis B virus (HBV) reactivation in kidney transplant recipients has been reported in 3% to 9% of anti-HBc antibody (HBcAb)-positive HBs antigen (HBsAg)-negative patients. It has not been studied...